Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies to provide direct access to their popular obesity meds. Thursday morning, ...

Eli Lilly and Novo Nordisk have rebutted claims that they have partnered with telehealth provider Mangoceuticals, sending the online company's shares back down after an initial rise. On 13 November, ...

(Reuters) -Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc, spokespeople for both companies said, rejecting a press release issued by ...

(Reuters) — Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth provider disclosed it had arrangements with the two drugmakers.

Indiana University and Eli Lilly are working together to expand clinical trials in the state. IU President Pamela Whitten and ...